BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 22086883)

  • 1. Plasma 25-hydroxyvitamin D and risk of pancreatic cancer.
    Wolpin BM; Ng K; Bao Y; Kraft P; Stampfer MJ; Michaud DS; Ma J; Buring JE; Sesso HD; Lee IM; Rifai N; Cochrane BB; Wactawski-Wende J; Chlebowski RT; Willett WC; Manson JE; Giovannucci EL; Fuchs CS
    Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):82-91. PubMed ID: 22086883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D-binding protein and pancreatic cancer: a nested case-control study.
    Piper MR; Freedman DM; Robien K; Kopp W; Rager H; Horst RL; Stolzenberg-Solomon RZ
    Am J Clin Nutr; 2015 Jun; 101(6):1206-15. PubMed ID: 25904602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of circulating vitamin D binding protein levels on the association between 25-hydroxyvitamin D and pancreatic cancer risk: a nested case-control study.
    Weinstein SJ; Stolzenberg-Solomon RZ; Kopp W; Rager H; Virtamo J; Albanes D
    Cancer Res; 2012 Mar; 72(5):1190-8. PubMed ID: 22232734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts.
    Bao Y; Giovannucci EL; Kraft P; Stampfer MJ; Ogino S; Ma J; Buring JE; Sesso HD; Lee IM; Gaziano JM; Rifai N; Pollak MN; Cochrane BB; Kaklamani V; Lin JH; Manson JE; Fuchs CS; Wolpin BM
    J Natl Cancer Inst; 2013 Jan; 105(2):95-103. PubMed ID: 23243202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers.
    Stolzenberg-Solomon RZ; Vieth R; Azad A; Pietinen P; Taylor PR; Virtamo J; Albanes D
    Cancer Res; 2006 Oct; 66(20):10213-9. PubMed ID: 17047087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.
    Stolzenberg-Solomon RZ; Jacobs EJ; Arslan AA; Qi D; Patel AV; Helzlsouer KJ; Weinstein SJ; McCullough ML; Purdue MP; Shu XO; Snyder K; Virtamo J; Wilkins LR; Yu K; Zeleniuch-Jacquotte A; Zheng W; Albanes D; Cai Q; Harvey C; Hayes R; Clipp S; Horst RL; Irish L; Koenig K; Le Marchand L; Kolonel LN
    Am J Epidemiol; 2010 Jul; 172(1):81-93. PubMed ID: 20562185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between 25-hydroxyvitamin D concentration and breast cancer risk in an Australian population: an observational case-control study.
    Bilinski K; Boyages J
    Breast Cancer Res Treat; 2013 Jan; 137(2):599-607. PubMed ID: 23239153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years.
    Eliassen AH; Warner ET; Rosner B; Collins LC; Beck AH; Quintana LM; Tamimi RM; Hankinson SE
    Cancer Res; 2016 Sep; 76(18):5423-30. PubMed ID: 27530324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival.
    Yuan C; Qian ZR; Babic A; Morales-Oyarvide V; Rubinson DA; Kraft P; Ng K; Bao Y; Giovannucci EL; Ogino S; Stampfer MJ; Gaziano JM; Sesso HD; Buring JE; Cochrane BB; Chlebowski RT; Snetselaar LG; Manson JE; Fuchs CS; Wolpin BM
    J Clin Oncol; 2016 Aug; 34(24):2899-905. PubMed ID: 27325858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.
    Wu K; Feskanich D; Fuchs CS; Willett WC; Hollis BW; Giovannucci EL
    J Natl Cancer Inst; 2007 Jul; 99(14):1120-9. PubMed ID: 17623801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum 25-hydroxyvitamin D and risk of lung cancer in male smokers: a nested case-control study.
    Weinstein SJ; Yu K; Horst RL; Parisi D; Virtamo J; Albanes D
    PLoS One; 2011; 6(6):e20796. PubMed ID: 21695165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial.
    Stolzenberg-Solomon RZ; Hayes RB; Horst RL; Anderson KE; Hollis BW; Silverman DT
    Cancer Res; 2009 Feb; 69(4):1439-47. PubMed ID: 19208842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint effects of colorectal cancer susceptibility loci, circulating 25-hydroxyvitamin D and risk of colorectal cancer.
    Hiraki LT; Joshi AD; Ng K; Fuchs CS; Ma J; Hazra A; Peters U; Karlson EW; Giovannucci E; Kraft P; Chan AT
    PLoS One; 2014; 9(3):e92212. PubMed ID: 24670869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Vitamin D Levels and Risk of Colorectal Cancer in Women.
    Chandler PD; Buring JE; Manson JE; Giovannucci EL; Moorthy MV; Zhang S; Lee IM; Lin JH
    Cancer Prev Res (Phila); 2015 Aug; 8(8):675-82. PubMed ID: 25813525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Vitamin D and Colorectal Cancer Risk: An International Pooling Project of 17 Cohorts.
    McCullough ML; Zoltick ES; Weinstein SJ; Fedirko V; Wang M; Cook NR; Eliassen AH; Zeleniuch-Jacquotte A; Agnoli C; Albanes D; Barnett MJ; Buring JE; Campbell PT; Clendenen TV; Freedman ND; Gapstur SM; Giovannucci EL; Goodman GG; Haiman CA; Ho GYF; Horst RL; Hou T; Huang WY; Jenab M; Jones ME; Joshu CE; Krogh V; Lee IM; Lee JE; Männistö S; Le Marchand L; Mondul AM; Neuhouser ML; Platz EA; Purdue MP; Riboli E; Robsahm TE; Rohan TE; Sasazuki S; Schoemaker MJ; Sieri S; Stampfer MJ; Swerdlow AJ; Thomson CA; Tretli S; Tsugane S; Ursin G; Visvanathan K; White KK; Wu K; Yaun SS; Zhang X; Willett WC; Gail MH; Ziegler RG; Smith-Warner SA
    J Natl Cancer Inst; 2019 Feb; 111(2):158-169. PubMed ID: 29912394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study of plasma vitamin D metabolites, vitamin D receptor polymorphisms, and prostate cancer.
    Li H; Stampfer MJ; Hollis JB; Mucci LA; Gaziano JM; Hunter D; Giovannucci EL; Ma J
    PLoS Med; 2007 Mar; 4(3):e103. PubMed ID: 17388667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer.
    Tworoger SS; Lee IM; Buring JE; Rosner B; Hollis BW; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):783-8. PubMed ID: 17416771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating 25-hydroxyvitamin D levels in relation to blood pressure parameters and hypertension in the Shanghai Women's and Men's Health Studies.
    Dorjgochoo T; Ou Shu X; Xiang YB; Yang G; Cai Q; Li H; Ji BT; Cai H; Gao YT; Zheng W
    Br J Nutr; 2012 Aug; 108(3):449-58. PubMed ID: 22365135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels of 25-hydroxyvitamin D and risk of breast cancer: a nested case-control study.
    Scarmo S; Afanasyeva Y; Lenner P; Koenig KL; Horst RL; Clendenen TV; Arslan AA; Chen Y; Hallmans G; Lundin E; Rinaldi S; Toniolo P; Shore RE; Zeleniuch-Jacquotte A
    Breast Cancer Res; 2013 Feb; 15(1):R15. PubMed ID: 23442740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study.
    Jenab M; Bueno-de-Mesquita HB; Ferrari P; van Duijnhoven FJ; Norat T; Pischon T; Jansen EH; Slimani N; Byrnes G; Rinaldi S; Tjønneland A; Olsen A; Overvad K; Boutron-Ruault MC; Clavel-Chapelon F; Morois S; Kaaks R; Linseisen J; Boeing H; Bergmann MM; Trichopoulou A; Misirli G; Trichopoulos D; Berrino F; Vineis P; Panico S; Palli D; Tumino R; Ros MM; van Gils CH; Peeters PH; Brustad M; Lund E; Tormo MJ; Ardanaz E; Rodríguez L; Sánchez MJ; Dorronsoro M; Gonzalez CA; Hallmans G; Palmqvist R; Roddam A; Key TJ; Khaw KT; Autier P; Hainaut P; Riboli E
    BMJ; 2010 Jan; 340():b5500. PubMed ID: 20093284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.